ClinicalTrials.gg
Not yet recruitingNCT06250907Updated Feb 9, 2024

Accuracy of Implant Placement for Patients With Mandibular Reconstruction Using Dynamic Navigation and Static Guides

An interventional study of The guidance of dynamic navigation and The guidance of static template in Mandibular Deficiency, sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. Not yet recruiting. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-09.

Sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

To evaluate and compare the accuracy of implant placement using dynamic navigation technique versus static template technique in patients with bone tissue flap reconstruction of mandibular defects, thus further guiding the clinical application of dynamic navigation systems to assist in conventional implant placement in patients with mandibular defects.

02

Conditions studied

  • Mandibular Deficiency

Browse trials for

03

In context

Micrognathism

26 studies on the registry are indexed under Micrognathism; 7 are open to participants now.

This study's planned enrollment of 20 is below the median of 24 across 22 interventional studies indexed under Micrognathism.

Browse Micrognathism studies →

Lead sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University is the lead sponsor of 164 studies on the registry; 73 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female patients between the ages of 18 and 70 (inclusive)
  • Mandibular defects (including Class I defects, limited to the body of the mandible; Class II defects, muscular-mandibular region defects and Class III defects, chin protrusion-muscular-mandibular region defects), which have been reconstructed by mandibular vascularization of free iliac bone, and fibular composite muscular flap grafts for greater than 3 months
  • Normal mouth opening (≥ 40 mm)
  • Trialists voluntarily signed an form before performing any research-related experimental steps.

Exclusion criteria

Exclusion Criteria:

  • Presence of localized inflammation in adjacent teeth, including uncontrolled periodontitis (periodontal probing to a depth of >4 mm)
  • Presence of untreated acute and chronic apical periodontitis in adjacent teeth
  • Oral mucosal lesions (e.g., lichen planus)
  • Adjacent teeth with space-occupying lesions (including cysts, tumors, etc.)
  • Systemic diseases affecting bone healing, wound healing and dental implant treatment (e.g., uncontrolled diabetes mellitus, fasting blood glucose ≥ 8.8 mmol/L despite medication)
  • Uncontrolled and unstabilized severe hypertension
  • to routine implant surgery and oral surgery
  • Heart disease (Class II or above)
  • Patients with liver or kidney insufficiency or abnormality
  • Obese patients with (BMI) > 28 kg/m2
  • Patients with a history of full-dose radiotherapy, localized radiotherapy to the head or neck
  • Patients requiring long-term high-dose therapy
  • Patients who are receiving or have received in the last 3 months medications (e.g., bisphosphonates) that may affect or promote bone metabolism
  • Consecutive antibiotic therapy or chronic anti-inflammatory therapy (≥3 times per week) within the first 4 weeks of starting the procedure
  • Alcohol or chronic substance abuse
  • patients
  • Smoking/tobacco equivalents/chewing tobacco >10 cigarettes per day
  • Physical or mental impairment that interferes with the performance of oral hygiene care
  • Female patients who are pregnant or breastfeeding
  • Patients who, in the opinion of the investigator, have poor compliance and cannot participate in the trial
  • Patients who have participated in a clinical trial of another drug or device within 30 days prior to the start of the procedure (Study Day 0)
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Dynamic navigation

    Procedure: The guidance of dynamic navigation

  • Active comparator
    Static template

    Procedure: The guidance of static template

Interventions

  • ProcedureThe guidance of dynamic navigation

    Osteotomy and implant placement with the guidance of dynamic navigation

  • ProcedureThe guidance of static template

    Osteotomy and implant placement with the guidance of static template

06

What researchers measure

Primary outcomes

  1. Three-dimensional implant placement accuracy of apical point

    The postoperative cone beam computed tomography (CBCT) was aligned to the preoperative plan in specific software, and the three-dimensional coordinates of the preoperatively planned and actual postoperative implant placement positions were measured separately, from which the three-dimensional distance (in mm) between the apical point of the actual implant and the apical point of the virtual implant was calculated.

    Time frame: Postoperative day 2±1

Secondary outcomes

  1. Three-dimensional implant placement accuracy of coronal point

    The postoperative CBCT was aligned to the preoperative plan in specific software, and the three-dimensional coordinates of the preoperatively planned and actual postoperative implant placement positions were measured separately, from which the three-dimensional distance (in mm) between the coronal point of the actual implant and the coronal point of the virtual implant was calculated.

    Time frame: Postoperative day 2±1

  2. Three-dimensional implant placement angular accuracy

    The postoperative CBCT was aligned to the preoperative implant placement plan in specific software to measure the three-dimensional coordinates of the preoperative plan and the actual postoperative implant placement position, respectively, and to calculate the angle (°) between the actual implant and the mid-axis of the virtual implant accordingly.

    Time frame: Postoperative day 2±1

  3. Operation time

    From the beginning of anesthesia to the complete removal of the static template or navigation reference frame.

    Time frame: Intraoperative

  4. Patient subjective satisfaction

    Evaluating patient satisfaction with the visual analogue scale

    Time frame: Postoperative day 14±1

  5. Failure rate during implant healing period

    1. According to the definition of Albrektsson and Zarb in 1986, the healing period is considered successful if the following conditions are met: no loosening of the implant after removal of the upper restoration; no peri-implant radiolucency; no peri-implant bone instability; and no pain. Implant retention was evaluated according to three levels: good osseointegration, poor osseointegration, and implant failure. 2. Implant survival rate = (N total - N failure)/(N total) × 100%.

    Time frame: Postoperative day 90±7

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06250907
Responsible party
Sponsor
First posted
Feb 9, 2024
Start date
Feb 29, 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
Feb 9, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion